Janssen

Rybrevant

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / Rybrevant – J9061

Manufacturer:

Janssen

Name:

Rybrevant

HCPCS Code Descriptor:

Injection, amivantamab-vmjw, 2 mg

Category:

J Code

HCPCS:

J9061

NDC(s):

57894-0501-01

Primary Type:

Oncology

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

Rybrevant is an Oncology drug manufactured by Janssen and administered via the Intravenous route of administration. The J Code: J9061 is aligned to the drug Rybrevant.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

1/1/22

HCPCS Effective Date:

1/1/22

HCPCS Short Description:

Inj, amivantamab-vmjw

Billing and Coding Guide:

https://www.janssencarepath.com/hcp/sites/www.janssencarepath-v2.com.hcp/files/rybrevant-coding-and-billing.pdf?v=188

Patient Assistance:

http://www.jjpaf.org/